+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Pharmaceuticals Market by Type, Route of Administration, Application, End User - Global Forecast 2025-2030- Product Image
Animal Pharmaceuticals Market by Type, Route of Administration, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Animal Pharmaceuticals Market by Type, Route of Administration, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337791
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Pharmaceuticals Market grew from USD 58.07 billion in 2023 to USD 62.99 billion in 2024. It is expected to continue growing at a CAGR of 8.61%, reaching USD 103.57 billion by 2030.

The animal pharmaceuticals market encompasses products tailored for diagnosing, treating, and preventing diseases in animals, including livestock, pets, and exotic species. This segment is vital for maintaining animal health, improving livestock productivity, and ensuring food safety, influencing sectors like agriculture, pet care, and veterinary healthcare. A surge in pet ownership, rising expenditure on animal healthcare, and growing awareness about zoonotic diseases drive the market. Moreover, increasing demand for animal-derived food products necessitates advancements in livestock health management. In addition to traditional applications such as antibiotics and vaccines, there is a growing inclination towards probiotics, feed additives, and personalized medicine driven by innovations in biotechnology and genetic engineering. Key influencers of growth include enhanced R&D activities, regulatory frameworks promoting animal health, and technological advancements in pharmaceutical formulations. Opportunities lie in expanding emerging markets, developing novel therapeutics for rare animal diseases, and catering to rising consumer demands for sustainable and organic animal health solutions. However, market growth is challenged by stringent regulatory approvals, high R&D costs, and growing concerns over antibiotic resistance. Additionally, economic fluctuations and animal welfare regulations are hurdles manufacturers must navigate. Addressing these challenges, innovation can thrive in creating alternative health solutions and precision medicine tailored to individual animal needs. The integration of AI and IoT in monitoring animal health and streamlining pharmaceutical distribution networks presents significant growth avenues. Emphasizing sustainability in production and operation, investing in biosecurity solutions, and enhancing consumer education regarding animal health products can further propel industry growth. Businesses should focus on collaborative ventures for knowledge sharing, diversifying product portfolios to include natural and organic solutions, and leveraging digital platforms for enhanced market reach to maintain competitiveness in this dynamic market landscape.

Understanding Market Dynamics in the Animal Pharmaceuticals Market

The Animal Pharmaceuticals Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
    • Significant growth experienced in livestock population
    • Emergence of government mandatory medication and vaccinations
  • Market Restraints
    • High costs of animal pharmaceuticals along with limited awareness and education among pet owners
  • Market Opportunities
    • Growing demand for organic and natural animal pharmaceuticals
    • Increasing emergence of the precision medicine tailored for individual animals
  • Market Challenges
    • Increasing concern over antibiotic resistance due to overuse in animal farms

Exploring Porter’s Five Forces for the Animal Pharmaceuticals Market

Porter’s Five Forces framework further strengthens the insights of the Animal Pharmaceuticals Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Animal Pharmaceuticals Market

External macro-environmental factors deeply influence the performance of the Animal Pharmaceuticals Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Animal Pharmaceuticals Market

The Animal Pharmaceuticals Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Animal Pharmaceuticals Market

The Animal Pharmaceuticals Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Animal Pharmaceuticals Market

The Animal Pharmaceuticals Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Alivira Animal Health Limited, Aurora Pharmaceutical, Inc., Bimeda Holdings PLC, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, Huvepharma, Inc., IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corp., Nippon Zenyaku Kogyo Co., Ltd., Norbrook Laboratories, Nutreco N.V., Orion Corporation, Ourofino Saúde Animal, Perrigo Company plc, PetIQ, LLC, Phibro Animal Health Corporation, Precision Science, Sanofi-Aventis Groupe S.A., Vesper Group, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Vaccine
      • Inactivated (Killed)
      • Modified/ Attenuated Live
    • Veterinary Drugs
      • Analgesics
      • Anti-infectives
      • Anti-inflammatory
      • Parasiticides
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Application
    • Aquatic Animals
    • Companion Animals
    • Livestock Animals
  • End User
    • Hospitals
    • Laboratories
    • Veternary Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
5.1.1.2. Significant growth experienced in livestock population
5.1.1.3. Emergence of government mandatory medication and vaccinations
5.1.2. Restraints
5.1.2.1. High costs of animal pharmaceuticals along with limited awareness and education among pet owners
5.1.3. Opportunities
5.1.3.1. Growing demand for organic and natural animal pharmaceuticals
5.1.3.2. Increasing emergence of the precision medicine tailored for individual animals
5.1.4. Challenges
5.1.4.1. Increasing concern over antibiotic resistance due to overuse in animal farms
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing usage of veterinary drugs indispensable for acute treatments
5.2.2. End User: Evolving usage of the animal pharmaceuticals across the veterinary clinics
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Animal Pharmaceuticals Market, by Type
6.1. Introduction
6.2. Vaccine
6.2.1. Inactivated (Killed)
6.2.2. Modified/ Attenuated Live
6.3. Veterinary Drugs
6.3.1. Analgesics
6.3.2. Anti-infectives
6.3.3. Anti-inflammatory
6.3.4. Parasiticides
7. Animal Pharmaceuticals Market, by Route of Administration
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical
8. Animal Pharmaceuticals Market, by Application
8.1. Introduction
8.2. Aquatic Animals
8.3. Companion Animals
8.4. Livestock Animals
9. Animal Pharmaceuticals Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Laboratories
9.4. Veternary Clinics
10. Americas Animal Pharmaceuticals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Animal Pharmaceuticals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Animal Pharmaceuticals Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Zoetis Enhances Feline Care with U.S. Launch of Bonqat Pregabalin Oral Solution
13.3.2. Zoetis and Blacksmith Medicines Collaborate on Novel Antibiotics to Combat Resistant Bacteria and Enhance Animal Health
13.3.3. Merck & Co. Bolsters Aquaculture Segment with Strategic Acquisition of Elanco's Aqua Business
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ANIMAL PHARMACEUTICALS MARKET DYNAMICS
TABLE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY INACTIVATED (KILLED), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY MODIFIED/ ATTENUATED LIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 51. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 52. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 83. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 84. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 89. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 90. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 101. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 102. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 137. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 138. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 157. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 163. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 175. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 192. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 193. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 216. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 217. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 222. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 223. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 265. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Animal Pharmaceuticals Market, which are profiled in this report, include:
  • Alivira Animal Health Limited
  • Aurora Pharmaceutical, Inc.
  • Bimeda Holdings PLC
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Neogen Corp.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Norbrook Laboratories
  • Nutreco N.V.
  • Orion Corporation
  • Ourofino Saúde Animal
  • Perrigo Company plc
  • PetIQ, LLC
  • Phibro Animal Health Corporation
  • Precision Science
  • Sanofi-Aventis Groupe S.A.
  • Vesper Group
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 62.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 103.57 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (November 4, 2025) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (November 4, 2025)

  • Conference
  • 1 Day
  • Global
Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Veterinary Therapeutics Market by Product, Animal, Route of Administration, End User - Global Forecast 2025-2030 - Product Image

Veterinary Therapeutics Market by Product, Animal, Route of Administration, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From

About the Animal Pharmaceuticals Market

The Animal Pharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs and other medical products for animals. These products are used to treat, prevent, and diagnose diseases in animals, as well as to improve their health and well-being. Animal pharmaceuticals are used in a variety of species, including companion animals, livestock, and wildlife. Animal pharmaceuticals are regulated by the Food and Drug Administration (FDA) and the Veterinary Medicine Advisory Committee (VMAC). The FDA is responsible for ensuring the safety and efficacy of animal drugs, while the VMAC provides advice and guidance on the development and approval of animal drugs. Some of the major companies in the Animal Pharmaceuticals market include Zoetis, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, and Boehringer Ingelheim Animal Health. These companies are involved in the development, production, and marketing of animal pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.